{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:25:58Z","timestamp":1793179558158,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ard.2026.05.010","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:24:49Z","timestamp":1784978689000},"page":"1904-1910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["2026 EULAR updated standardised operating procedures and methods for the development of recommendations or points to consider for the diagnosis and management of people with rheumatic and musculoskeletal diseases"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-7023","authenticated-orcid":false,"given":"George E.","family":"Fragoulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.\u202fM.","family":"Landew\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Aletaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"\u00c1lvaro-Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Gossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Lupatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souzi","family":"Makri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke Helene","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Kiltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ard.2026.05.010_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071188","article-title":"Evidence-based practice models and frameworks in the healthcare setting: a scoping review","volume":"13","author":"Dusin","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ard.2026.05.010_bib0002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/annrheumdis-2014-206350","article-title":"2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations","volume":"74","author":"van der Heijde","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ard.2026.05.010_bib0003","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/ard.2004.023697","article-title":"EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees","volume":"63","author":"Dougados","year":"2004","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ard.2026.05.010_bib0004","unstructured":"EULAR. EULAR standard operating procedures for task forces. Version 56 [Internet]; 2025 [cited 2026 June 22]. Availble from: https:\/\/www.eular.org\/recommendations\/points-to-consider-task-forces-project-applications."},{"issue":"3","key":"10.1016\/j.ard.2026.05.010_bib0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.43218","article-title":"EULAR\/American College of Rheumatology risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia","volume":"78","author":"van Steenbergen","year":"2026","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ard.2026.05.010_bib0006","unstructured":"EULAR. EULAR recommendations: EULAR\/ACR collaborative projects [Internet]; 2026 [cited Jan 206]. Available from: https:\/\/www.eular.org\/recommendations-eular-acr"},{"key":"10.1016\/j.ard.2026.05.010_bib0007","unstructured":"American College of Rheumatology. Call for criteria proposals [Internet]; 2026 [cited Jan 2026]. Available from: https:\/\/rheumatology.org\/call-for-criteria-proposals"},{"issue":"1","key":"10.1016\/j.ard.2026.05.010_bib0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.05.010_bib0009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ard.2025.08.021","volume":"85","author":"Antoniou","year":"2026","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ard.2026.05.010_bib0010","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5","author":"Higgins","year":"2024"},{"key":"10.1016\/j.ard.2026.05.010_bib0011","unstructured":"GRADE. The GRADE Working Group [Internet]; 2026 [cited 2026 June 22]. Available from: https:\/\/www.gradeworkinggroup.org\/"},{"issue":"2","key":"10.1016\/j.ard.2026.05.010_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-004032","article-title":"Synthesis of guidance available for assessing methodological quality and grading of evidence from qualitative research to inform clinical recommendations: a systematic literature review","volume":"10","author":"Sekhon","year":"2024","journal-title":"RMD Open."},{"key":"10.1016\/j.ard.2026.05.010_bib0013","unstructured":"Centre for Evidence-Based Medicine. OCEBM levels of evidence [Internet]; 2026 [cited 2026 June 22]. Available from: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence."},{"issue":"3","key":"10.1016\/j.ard.2026.05.010_bib0014","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/014107680309600304","article-title":"Five steps to conducting a systematic review","volume":"96","author":"Khan","year":"2003","journal-title":"J R Soc Med."},{"issue":"7","key":"10.1016\/j.ard.2026.05.010_bib0015","first-page":"636","article-title":"Conducting a high-quality systematic review","volume":"52","author":"Shehata","year":"2025","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2026.05.010_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.ard.2026.05.010_bib0017","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.05.010_bib0018","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ard.2025.09.007","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update","volume":"85","author":"Fanouriakis","year":"2026","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.05.010_bib0019","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.ard.2026.05.010_bib0020","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.ard.2026.05.010_bib0021","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/ard-2024-225531","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update","volume":"83","author":"Gossec","year":"2024","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.ard.2026.05.010_bib0022","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","article-title":"European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update","volume":"75","author":"Gossec","year":"2016","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.ard.2026.05.010_bib0023","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.ard.2026.05.010_bib0024","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ard.2026.05.010_bib0025","unstructured":"EULAR. EULAR standard operating procedures for (post-TF) implementation projects [Internet]; 2026 [cited 2026 June 22]. Available from: https:\/\/www.eular.org\/sops-for-eular-post-tf-implementation-projects."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726002888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726002888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:08:51Z","timestamp":1791086931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726002888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0003496726002888"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.05.010","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2026 EULAR updated standardised operating procedures and methods for the development of recommendations or points to consider for the diagnosis and management of people with rheumatic and musculoskeletal diseases","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}